Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for Alopecia Areata don't fully meet patients' needs, indicating a need for better therapies.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

People with alopecia areata may have a higher risk of blood clots.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.

Topical corticosteroids are the preferred first treatment for children with Alopecia Areata.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

A man with four autoimmune diseases suggests a new category for multiple autoimmune syndrome.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

More inclusive research is needed to effectively treat frontal fibrosing alopecia in Black patients.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Galea fixation is a safe and effective way to remove bald scalp with minimal scarring and reduced stretch-back.

Some alternative treatments for hair loss might work, but more research is needed.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Platelet-rich plasma therapy may help treat folliculitis decalvans but benefits might not last without ongoing treatment.

Onabotulinumtoxin-A effectively treated a painful scalp condition when other treatments failed.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Consider benefits and risks of new alopecia treatments for safety.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Hair follicle cells resist turning into skin cells.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Adalimumab improved folliculitis decalvans in most patients.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Significant hair regrowth doesn't always mean complete hair recovery in alopecia areata.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.